BlackRock Health Sciences Term Trust (NYSE:BMEZ) Trading Up 1% – What’s Next?

BlackRock Health Sciences Term Trust (NYSE:BMEZ) shot up 1% during trading on Thursday . The stock traded as high as $14.52 and last traded at $14.47. 151,282 shares changed hands during trading, a decline of 38% from the average session volume of 245,519 shares. The stock had previously closed at $14.32.

BlackRock Health Sciences Term Trust Stock Performance

The company has a 50 day moving average price of $14.26 and a 200 day moving average price of $14.75.

Institutional Trading of BlackRock Health Sciences Term Trust

Several institutional investors have recently added to or reduced their stakes in the company. CWM LLC boosted its stake in BlackRock Health Sciences Term Trust by 25.6% in the 4th quarter. CWM LLC now owns 3,336 shares of the company’s stock valued at $50,000 after purchasing an additional 680 shares during the period. Steward Partners Investment Advisory LLC boosted its stake in BlackRock Health Sciences Term Trust by 4.9% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 14,687 shares of the company’s stock valued at $221,000 after purchasing an additional 688 shares during the period. Private Advisor Group LLC boosted its stake in BlackRock Health Sciences Term Trust by 3.5% in the 3rd quarter. Private Advisor Group LLC now owns 28,039 shares of the company’s stock valued at $404,000 after purchasing an additional 940 shares during the period. PMG Family Office LLC boosted its stake in BlackRock Health Sciences Term Trust by 4.9% in the 1st quarter. PMG Family Office LLC now owns 28,227 shares of the company’s stock valued at $405,000 after purchasing an additional 1,320 shares during the period. Finally, Kestra Advisory Services LLC bought a new stake in BlackRock Health Sciences Term Trust in the 4th quarter valued at $26,000.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.